402 results on '"Buckanovich, Ronald J."'
Search Results
2. EGFL6 promotes endometrial cancer cell migration and proliferation
3. Development of substituted benzimidazoles as inhibitors of human aldehyde dehydrogenase 1A isoenzymes
4. Evaluating the trophic transfer of PCBs from fish to humans: Insights from a synergism of environmental monitoring and physiologically-based pharmacokinetic modeling
5. A putative role for ALDH inhibitors and chemoprevention of BRCA-mutation-driven tumors
6. SI Correction
7. Generation and characterization of humanized affinity-matured EGFL6 antibodies for ovarian cancer therapy
8. Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study
9. Development of 2,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of aldehyde dehydrogenase 1A (ALDH1A) as potential adjuncts to ovarian cancer chemotherapy
10. Engineered 3D Model of Cancer Stem Cell Enrichment and Chemoresistance
11. Acetate drives ovarian cancer quiescence via ACSS2-mediated acetyl-CoA production
12. Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth
13. A Novel Humanized Immune Stroma PDX Cancer Model for Therapeutic Studies
14. Single-cell analysis reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of ovarian cancer
15. Figure S4 from Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to Chemotherapy
16. Table S1 from Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to Chemotherapy
17. Data from Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to Chemotherapy
18. A phase 2 randomised discontinuation trial of cabozantinib in patients with ovarian carcinoma
19. Clinicopathological significance of endoplasmic reticulum stress proteins in ovarian carcinoma
20. Single-cell analysis reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of ovarian cancer
21. Data from CD24+ Ovarian Cancer Cells Are Enriched for Cancer-Initiating Cells and Dependent on JAK2 Signaling for Growth and Metastasis
22. Supplemental Figure 2 from CD24+ Ovarian Cancer Cells Are Enriched for Cancer-Initiating Cells and Dependent on JAK2 Signaling for Growth and Metastasis
23. Supplemental Figure 4 from CD24+ Ovarian Cancer Cells Are Enriched for Cancer-Initiating Cells and Dependent on JAK2 Signaling for Growth and Metastasis
24. Supplemental Figure 3 from CD24+ Ovarian Cancer Cells Are Enriched for Cancer-Initiating Cells and Dependent on JAK2 Signaling for Growth and Metastasis
25. Supplemental Figure 1 from Therapeutic Impact of Nanoparticle Therapy Targeting Tumor-Associated Macrophages
26. Data from Therapeutic Impact of Nanoparticle Therapy Targeting Tumor-Associated Macrophages
27. Supplemental Figure 1 from CD24+ Ovarian Cancer Cells Are Enriched for Cancer-Initiating Cells and Dependent on JAK2 Signaling for Growth and Metastasis
28. Data from Targeting Therapeutic Resistance and Multinucleate Giant Cells in CCNE1-Amplified HR-Proficient Ovarian Cancer
29. Supplemental Figure 5 from CD24+ Ovarian Cancer Cells Are Enriched for Cancer-Initiating Cells and Dependent on JAK2 Signaling for Growth and Metastasis
30. Supplementary Data from Targeting Therapeutic Resistance and Multinucleate Giant Cells in CCNE1-Amplified HR-Proficient Ovarian Cancer
31. Supplementary Figure 7 from Personalized Medicine–Based Approach to Model Patterns of Chemoresistance and Tumor Recurrence Using Ovarian Cancer Stem Cell Spheroids
32. Supplementary Figure S1 and S2 from Personalized Medicine–Based Approach to Model Patterns of Chemoresistance and Tumor Recurrence Using Ovarian Cancer Stem Cell Spheroids
33. Supplementary Figure 8 from Personalized Medicine–Based Approach to Model Patterns of Chemoresistance and Tumor Recurrence Using Ovarian Cancer Stem Cell Spheroids
34. Supplementary Figure 5 from Personalized Medicine–Based Approach to Model Patterns of Chemoresistance and Tumor Recurrence Using Ovarian Cancer Stem Cell Spheroids
35. Supplementary Methods from EGFL6 Regulates the Asymmetric Division, Maintenance, and Metastasis of ALDH+ Ovarian Cancer Cells
36. Supplementary Figure 6 from Personalized Medicine–Based Approach to Model Patterns of Chemoresistance and Tumor Recurrence Using Ovarian Cancer Stem Cell Spheroids
37. Data from EGFL6 Regulates the Asymmetric Division, Maintenance, and Metastasis of ALDH+ Ovarian Cancer Cells
38. Supplementary Figures 1-8 from EGFL6 Regulates the Asymmetric Division, Maintenance, and Metastasis of ALDH+ Ovarian Cancer Cells
39. Supplementary Figure 2 from Depletion of Dendritic Cells Delays Ovarian Cancer Progression by Boosting Antitumor Immunity
40. Supplementary Figure 1 from Depletion of Dendritic Cells Delays Ovarian Cancer Progression by Boosting Antitumor Immunity
41. Data Supplement from Depletion of Dendritic Cells Delays Ovarian Cancer Progression by Boosting Antitumor Immunity
42. Data from A Novel Model for Evaluating Therapies Targeting Human Tumor Vasculature and Human Cancer Stem–like Cells
43. Data from Depletion of Dendritic Cells Delays Ovarian Cancer Progression by Boosting Antitumor Immunity
44. Supplementary Figure 3 from Depletion of Dendritic Cells Delays Ovarian Cancer Progression by Boosting Antitumor Immunity
45. Supplementary Figure Legends from Depletion of Dendritic Cells Delays Ovarian Cancer Progression by Boosting Antitumor Immunity
46. Data from Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient Survival
47. Supplementary Tables 1-3, Figures 1-3 from Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient Survival
48. Supplementary Table 2 from A Novel Model for Evaluating Therapies Targeting Human Tumor Vasculature and Human Cancer Stem–like Cells
49. Supplementary Table 1 from A Novel Model for Evaluating Therapies Targeting Human Tumor Vasculature and Human Cancer Stem–like Cells
50. Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to Chemotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.